Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- a... von Bergman, Martin, Tundia, Namita, Martin, Naomi, Suboticki, Jessica L, Patel, Jayeshkumar, Goldschmidt, Debbie, Song, Yan, Wright, Grace C

Volltext

Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY von Strand, Vibeke, Tundia, Namita, Wells, Alvin, Buch, Maya H, Radominski, Sebastiao C, Camp, Heidi S, Friedman, Alan, Suboticki, Jessica L, Dunlap, Kendall, Goldschmidt, Debbie, Bergman, Martin

Volltext

Correction: Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic... von Bergman, Martin, Tundia, Namita, Martin, Naomi, Suboticki, Jessica L., Patel, Jayeshkumar, Goldschmidt, Debbie, Song, Yan, Wright, Grace C.

Volltext

MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis von Charles-Schoeman, Christina, Choy, Ernest, McInnes, Iain B, Mysler, Eduardo, Nash, Peter, Yamaoka, Kunihiro, Lippe, Ralph, Khan, Nasser, Shmagel, Anna K, Palac, Hannah, Suboticki, Jessica, Curtis, Jeffrey R

Volltext

P135 Efficacy and safety of upadacitinib in TNFi inadequate responders with rheumatoid arthritis from three Phase 3 clinical trials von Fleischmann, Roy, Bessette, Louis, Hall, Stephen, Sparks, Jeffrey, Jain, Manish, Kakehasi, Adriana, Song, Yanna, Meerwein, Sebastian, DeMasi, Ryan, Suboticki, Jessica, Rubbert-Roth, Andrea

Volltext

OA27 Sustainability of response between upadacitinib and adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE trial von Buch, Maya H, Nash, Peter, Kavanaugh, Arthur, Combe, Bernard, Bessette, Louis, Song, In-Ho, Shaw, Tim, Song, Yanna, Suboticki, Jessica L, Fleischmann, Roy

Volltext

Additional file 1 of Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antir... von Bergman, Martin, Tundia, Namita, Martin, Naomi, Suboticki, Jessica L., Patel, Jayeshkumar, Goldschmidt, Debbie, Song, Yan, Wright, Grace C.

Volltext bestellen

Additional file 2 of Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antir... von Bergman, Martin, Tundia, Namita, Martin, Naomi, Suboticki, Jessica L., Patel, Jayeshkumar, Goldschmidt, Debbie, Song, Yan, Wright, Grace C.

Volltext bestellen